CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer
Ontology highlight
ABSTRACT: This is an open label, fixed dose, phase Ib trial of anti-CEA CAR-T cell infusions delivered via the hepatic artery or splenic vein using the Surefire Infusion System (SIS) for patients with CEA-expressing liver metastases or pancreas cancer.
DISEASE(S): Neoplasm Metastasis,Liver Metastases,Gastric Cancer,Colorectal Cancer,Liver Neoplasms,Pancreatic Neoplasms,Breast Cancer
PROVIDER: 2221147 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA